Rachel King
Founder at GLYCOMIMETICS, INC.
Net worth: 463 454 $ as of 31/05/2024
Network origin in Rachel King first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Biotechnology | 40 | |
Public Company | Pharmaceuticals: Major | 29 | |
Learning Undefeated, Inc.
Learning Undefeated, Inc. Investment Trusts/Mutual FundsMiscellaneous Learning Undefeated, Inc. is a non-profit organization that provides STEM education opportunities for underserved communities. The non-profit company is based in Gaithersburg. The American company's flagship education program features mobile STEM labs that have provided hands-on learning opportunities to more than 200,000 K-12 students in 18 states since 2003. The company also operates several other celebrated STEM education programs including the Young Science Explorers program, a summer camp for middle school students, and the Advancing Tomorrow's Leaders in STEM (ATLAS) college and career exploration program. Learning Undefeated is driving race and gender equity in STEM through experiential and deep-impact learning experiences for students from under-resourced communities.
12
| Non-Profit Organization | Investment Trusts/Mutual Funds | 12 |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
MdBio, Inc.
MdBio, Inc. Miscellaneous Commercial ServicesCommercial Services MdBio, Inc. is based in Frederick, MD. MdBio provides medical-grade, patient-tested full spectrum hemp and plant-based medicine products that are unique in the industry for their innovation, quality, and potency. Targeting ailments such as poor sleep, anxiety, pain, and weakened immune systems, their products naturally restore the body's endocannabinoid balance to maximize overall health and wellbeing in patients. Part of Maryland Technology Council, MdBio, Inc. is a company founded by four renowned medical doctors committed to providing therapeutic alternatives to pharmaceutical drugs. MdBio was acquired by Tech Council of Maryland, Inc. on February 07, 2006.
5
| Subsidiary | Miscellaneous Commercial Services | 5 |
Genetic Therapy, Inc.
Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD.
4
| Subsidiary | Miscellaneous Commercial Services | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Rachel King via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO Comptroller/Controller/Auditor Sales & Marketing Corporate Officer/Principal | |
IOMAI CORPORATION | Biotechnology | Director/Board Member Chief Executive Officer Founder Director of Finance/CFO Chief Operating Officer Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chairman Corporate Officer/Principal Director/Board Member | |
University of Maryland | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Masters Business Admin Undergraduate Degree | |
Stanford University | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Undergraduate Degree | |
TESARO INC | Pharmaceuticals: Major | Founder Chairman Director of Finance/CFO Director of Finance/CFO | |
MAXCYTE, INC. | Biotechnology | Director/Board Member Director/Board Member Founder Chairman | |
Brown University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
The Johns Hopkins University | College/University | Graduate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
IMMUNOGEN, INC. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member | |
Senseonics, Inc.
Senseonics, Inc. Electronic ComponentsElectronic Technology Senseonics, Inc. develops transformative glucose monitoring products. It develops Senseonics continuous glucose monitoring system, an implantable continuous glucose monitoring system, which includes a miniaturized sensor and receiver that is inserted into the subcutaneous space under the skin to wirelessly transmit glucose levels to an external receiver. The company was founded by Michael James Barrett and Arthur E. Colvin in 1996 and is headquartered in Germantown, MD. | Electronic Components | Chief Executive Officer Founder Director of Finance/CFO | |
EMERGENT BIOSOLUTIONS INC. | Pharmaceuticals: Major | Director of Finance/CFO Public Communications Contact General Counsel | |
Eximias Pharmaceutical Corp.
Eximias Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Eximias Pharmaceutical Corp. develops pharmaceuticals for treatment of cancer disorders. It offers its services in the mid-Atlantic areas. The company is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Sales & Marketing General Counsel Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Director/Board Member | |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
University of Michigan | College/University | Masters Business Admin Undergraduate Degree Doctorate Degree | |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | Financial Conglomerates | Director/Board Member Director/Board Member Director/Board Member | |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Public Communications Contact | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Sales & Marketing | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Doctorate Degree Masters Business Admin Masters Business Admin | |
SUPERNUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chairman Director of Finance/CFO | |
OPGEN, INC. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
VANDA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO | |
University of Virginia | College/University | Graduate Degree Undergraduate Degree | |
BIOGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
SENSEONICS HOLDINGS, INC. | Electronic Components | Director/Board Member Director of Finance/CFO | |
University of Pennsylvania | College/University | Corporate Officer/Principal Graduate Degree | |
BOSTON SCIENTIFIC CORPORATION | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
NEXIMMUNE, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
MedImmune Ventures, Inc.
MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Investment Managers | Founder Private Equity Investor | |
Vtesse, Inc.
Vtesse, Inc. BiotechnologyHealth Technology Vtesse, Inc. provides novel drugs for life-threatening rare diseases. It developed VTS-270, a modified form of cyclodextrin that has been evaluated in preclinical and clinical studies at institutes within the National Institutes of Health (NIH) to treat patients with Niemann-Pick Disease Type C (NPC). The firm is working with the NIH and other leading academic centers to advance clinical study of VTS-270 for NPC, and to conduct pre-clinical discovery and development of other novel drugs for NPC and other LSDs. The company was founded by Ben Machielse in 2015 and is headquartered in Gaithersburg, MD. | Biotechnology | Chairman Founder | |
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
Yale University | College/University | Doctorate Degree Undergraduate Degree | |
ENERGY HUNTER RESOURCES INC | Integrated Oil | Founder Director/Board Member | |
Lehigh University | College/University | Undergraduate Degree Undergraduate Degree | |
AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Santa Clara University | College/University | Masters Business Admin Masters Business Admin | |
TARGETED MICROWAVE SOLUTIONS INC. | Industrial Machinery | Chief Executive Officer Director/Board Member |
Statistics
International
United States | 49 |
United Kingdom | 2 |
Canada | 2 |
Sectoral
Health Technology | 29 |
Consumer Services | 12 |
Commercial Services | 4 |
Finance | 4 |
Electronic Technology | 3 |
Operational
Director/Board Member | 374 |
Corporate Officer/Principal | 196 |
Independent Dir/Board Member | 101 |
Undergraduate Degree | 86 |
Chairman | 82 |
Most connected contacts
Insiders | |
---|---|
Michael Barrett | 49 |
David Mott | 45 |
Evan S. Melrose | 32 |
Rajiv Indravadan Modi | 31 |
Douglas G. Watson | 30 |
Michael Perry | 28 |
Gary Evans | 25 |
Sven Arne Andréasson | 24 |
Gregg Alton | 22 |
William Snider | 21 |
Reinhard Ambros | 20 |
Steven Meltzer | 18 |
Kenneth Carter | 18 |
Mark Goldberg | 17 |
Scott Jackson | 15 |
- Stock Market
- Insiders
- Rachel King
- Company connections